Detalhe da pesquisa
1.
A blood-based immune marker for resistance to pembrolizumab in patients with metastatic urothelial cancer.
Cancer Immunol Immunother
; 72(3): 759-767, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-35976415
2.
Improved enrichment of circulating tumor cells from diagnostic leukapheresis product.
Cytometry A
; 103(11): 881-888, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37461156
3.
The PRO-RCC study: a long-term PROspective Renal Cell Carcinoma cohort in the Netherlands, providing an infrastructure for 'Trial within Cohorts' study designs.
BMC Cancer
; 23(1): 648, 2023 Jul 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37434119
4.
The impact of a 1-hour time interval between pazopanib and subsequent intake of gastric acid suppressants on pazopanib exposure.
Int J Cancer
; 148(11): 2799-2806, 2021 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33428771
5.
A prospective observational registry evaluating clinical outcomes of Radium-223 treatment in a nonstudy population.
Int J Cancer
; 147(4): 1143-1151, 2020 08 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31875956
6.
Prognostic Value of Novel Liquid Biomarkers in Patients with Metastatic Castration-Resistant Prostate Cancer Treated with Enzalutamide: A Prospective Observational Study.
Clin Chem
; 66(6): 842-851, 2020 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32408351
7.
Androgen receptor expression in circulating tumor cells of patients with metastatic breast cancer.
Int J Cancer
; 145(4): 1083-1089, 2019 08 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30761532
8.
Phase 1 study of everolimus and low-dose oral cyclophosphamide in patients with metastatic renal cell carcinoma.
Cancer Immunol Immunother
; 68(2): 319-329, 2019 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-30413837
9.
The effect of everolimus and low-dose cyclophosphamide on immune cell subsets in patients with metastatic renal cell carcinoma: results from a phase I clinical trial.
Cancer Immunol Immunother
; 68(3): 503-515, 2019 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-30652208
10.
Metronomic cyclophosphamide attenuates mTOR-mediated expansion of regulatory T cells, but does not impact clinical outcome in patients with metastatic renal cell cancer treated with everolimus.
Cancer Immunol Immunother
; 68(5): 787-798, 2019 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-30756132
11.
Mannose binding lectin and prediction of risk for chemotherapy induced febrile neutropenia in patients with a solid tumor.
Cancer Invest
; 37(3): 156-162, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30907154
12.
Effects of prednisone on docetaxel pharmacokinetics in men with metastatic prostate cancer: A randomized drug-drug interaction study.
Br J Clin Pharmacol
; 85(5): 986-992, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30737835
13.
DPYD genotype-guided dose individualisation of fluoropyrimidine therapy in patients with cancer: a prospective safety analysis.
Lancet Oncol
; 19(11): 1459-1467, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30348537
14.
Discontinuation of azacitidine in acute myeloid leukemia: a feasible option?
Ann Hematol
; 101(11): 2549-2550, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35927345
15.
Prognostic parameters for response to enzalutamide after docetaxel and abiraterone treatment in metastatic castration-resistant prostate cancer patients; a possible time relation.
Prostate
; 76(1): 32-40, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26390914
16.
A randomized phase 2 study exploring the role of bevacizumab and a chemotherapy-free approach in HER2-positive metastatic breast cancer: The HAT study (BOOG 2008-2003), a Dutch Breast Cancer Research Group trial.
Cancer
; 122(19): 2961-70, 2016 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-27315546
17.
Enzalutamide as a Fourth- or Fifth-Line Treatment Option for Metastatic Castration-Resistant Prostate Cancer.
Oncology
; 91(5): 267-273, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27544669
18.
An 8-gene mRNA expression profile in circulating tumor cells predicts response to aromatase inhibitors in metastatic breast cancer patients.
BMC Cancer
; 16: 123, 2016 Feb 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-26892682
19.
Unsafe testosterone-based dosing regimen of androgen deprivation therapy in patients with locally advanced or metastatic prostate cancer: a prematurely ended randomized controlled trial (MIDAS-trial).
Acta Oncol
; 60(4): 539-543, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-33356721
20.
CAST: A retrospective analysis of cabazitaxel and abiraterone acetate sequential treatment in patients with metastatic castrate-resistant prostate cancer previously treated with docetaxel.
Int J Cancer
; 136(6): E760-72, 2015 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25242736